Panx1 and drug discovery: from non-specific inhibitors to tailored drug compounds.

Pannexin (Panx)-1-mediated ATP release has been associated with a broad range of pathological conditions. Conversely, the use of Panx1-inhibitors has shown promising results in the medication of diseases, such as neuroinflammation, melanoma and epile…

Preview only. Read the full abstract at the source